Menactra Returns To Normal Schedule; FluMist Seeks CDC Contract
Executive Summary
FluMist CDC contract: MedImmune is negotiating a contract with the Centers for Disease Control & Prevention to supply its intranasal flu vaccine FluMist for the 2006-2007 season, VP & General Manager Mark Twyman says during a Oct. 25-26 meeting of CDC's Advisory Committee on Immunization Practices in Atlanta. The firm could supply the entire pediatric market by the 2008-2009 season, he says. Firm plans to produce 3 mil. doses of FluMist for the U.S. market for the current season and expects to have production, filling and distribution capacity for 20 mil. to 30 mil. doses for 2008-2009. MedImmune hopes to launch its refrigerator-stable version, CAIV-T (cold adapted influenza vaccine, trivalent), by next season. The firm hopes the non-freezer version will boost sluggish uptake...